Flow Neuroscience appoints new CEO

Swedish startup Flow Neuroscience has appointed Erin Sivyer Lee as CEO.

Flow is the creator of Europe’s first medically-approved brain stimulation headset and behavioural therapy app to treat depression at home.

Lee will focus on driving global growth to make the depression treatment readily accessible to US populations and pave the way for reimbursement within the UK and EU.

Lee joins Flow Neuroscience from Babylon Health where she was VP of Global Operations and led the rollout of Babylon in the US.

Her previous experience also includes executive roles at UBER and Google.

Lee said:

“I have always been drawn to the teams and technologies focused on improving human experiences on a global scale.

“The Flow team has built a truly transformational hardware-enabled platform that I believe will fundamentally change the way we understand and treat disorders like depression.”

Daniel Månsson, co-founder and CCO of Flow Neuroscience, said:

“Following a strong recruitment process, I’m confident that there is no one better to lead Flow Neuroscience.

“Erin brings a unique perspective from leading high-performance teams at some of the most successful companies in the world.

“Coupled with this, she has a personal passion for transforming how we treat depression and manage wider mental health.”

Flow has over 2000 active patients every month, with 81 per cent experiencing a reduction in their symptoms in the first three weeks of the treatment programme, the company said.

The headset harnesses tDCS – a non-invasive, gentle brain stimulation technique that uses electrical current to stimulate specific brain areas.

The technique has been validated across longitudinal clinical trials using double-blinded RCT studies showing that it is a safe and effective treatment for depression that provides a low-cost alternative with fewer side effects than current standard care options, such as antidepressants.